# Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

> **NCT04401982** · — · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 10 (actual)

## Conditions studied

- Ocular Hypertension
- Suspect Glaucoma

## Interventions

- **DRUG:** Netarsudil ophthalmic solution 0.02% one drop nightly for 1-2 weeks

## Key facts

- **NCT ID:** NCT04401982
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-02-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401982, "Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04401982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*